Revolutionize Precision Medicine

We unravel disease mechanisms
by identifying aberrant activities
of cell signaling pathways

events

High HH and low AR associated with resistance to ARDT in prostate cancer

news

InnoSIGN is developing a smart PCR test to predict which drug will work in a cancer patient